Evidence map›Paper›PMID 32699145›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

Calcium and hydroxyapatite binding site of human vitronectin provides insights to abnormal deposit formation.

Kyungsoo Shin, James E Kent, Chandan Singh, Lynn M Fujimoto, Jinghua Yu, Ye Tian, Wonpil Im, Francesca M Marassi

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Potential Targeting Mechanisms for Bone-Directed Therapies.International journal of molecular sciences · 2024
    Review
  5. Cell-cell communication in kidney fibrosis.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2024
    Review
  6. Article
  7. Calpain-specific breakdown fragment in human drusen.Histology and histopathology · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Kyungsoo ShinCancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037.ORCID 0000-0003-4836-8798
James E KentCancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037.ORCID 0000-0002-4856-525X
Chandan SinghCancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037.ORCID 0000-0001-8006-1329
Lynn M FujimotoCancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037.ORCID 0000-0002-7239-1501
Jinghua YuCancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037.
Ye TianCancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037.
Wonpil ImDepartment of Biological Sciences, Chemistry, and Bioengineering, Lehigh University, Bethlehem, PA 18015.ORCID 0000-0001-5642-6041
Francesca M MarassiCancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037; fmarassi@sbp.edu.ORCID 0000-0003-2695-5844
Sanford Burnham Prebys Medical Discovery Institute · USLehigh University · US

Funding

Tumor Microenvironment and Cancer ImmunologyP30CA030199 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI ELENA B PASQUALE · 1985 to 2026
$107.2M
Membrane Protein Effectors of Pathogen Interactions With HostR35GM118186 · NIGMS · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI Francesca M Marassi · 2016 to 2026
$8.5M
CIHRNCI NIH HHS P30 CA030199NIGMS NIH HHS R35 GM118186
6 · The paper itself

Abstract

The human blood protein vitronectin (Vn) is a major component of the abnormal deposits associated with age-related macular degeneration, Alzheimer's disease, and many other age-related disorders. Its accumulation with lipids and hydroxyapatite (HAP) has been demonstrated, but the precise mechanism for deposit formation remains unknown. Using a combination of solution and solid-state NMR experiments, cosedimentation assays, differential scanning fluorimetry (DSF), and binding energy calculations, we demonstrate that Vn is capable of binding both soluble ionic calcium and crystalline HAP, with high affinity and chemical specificity. Calcium ions bind preferentially at an external site, at the top of the hemopexin-like (HX) domain, with a group of four Asp carboxylate groups. The same external site is also implicated in HAP binding. Moreover, Vn acquires thermal stability upon association with either calcium ions or crystalline HAP. The data point to a mechanism whereby Vn plays an active role in orchestrating calcified deposit formation. They provide a platform for understanding the pathogenesis of macular degeneration and other related degenerative disorders, and the normal functions of Vn, especially those related to bone resorption.

Indexed as

Binding SitesCalciumDurapatiteHumansMacular DegenerationProtein BindingVitronectinCalciumDurapatiteVitronectindepositdrusenmacular degenerationNMRsolid state

Identifiers

PMID32699145
PMCPMC7414086
OpenAlexW3044095559

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.